Medical Care
Global Pediatrics Medicine Market Research Report 2024
- Feb 19, 24
- ID: 55820
- Pages: 99
- Figures: 190
- Views: 16
Pediatrics (also spelled paediatrics or pædiatrics) is the branch of medicine that involves the medical care of infants, children, and adolescents.This report anzlyed the medicines for pediatrics.
The global Pediatrics Medicine market was valued at US$ 161810 million in 2023 and is anticipated to reach US$ 216370 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pediatrics Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatrics Medicine.
Report Scope
The Pediatrics Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pediatrics Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatrics Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Novartis
Pfizer
Sanofi
Abbott
Bristol-Myers Squibb
Cipla
Eisai Pharmaceuticals
Eli Lilly
F. Hoffman-La Roche
Glenmark
Helsinn Healthcare
Heron Therapeutics
Ipca Laboratories
Lupin Pharmaceuticals
Merck Sharp & Dohme
RedHill
Sun Pharmaceutical Industries
Takeda Pharmaceutical
Segment by Type
Tablets
Caplets
Oral Liquid
Capsules
Other
Segment by Application
Respiratory diseases
Infectious diseases
Gastrointestinal diseases
CNS diseases
Oncological diseases
CVDs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatrics Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Pediatrics Medicine market was valued at US$ 161810 million in 2023 and is anticipated to reach US$ 216370 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pediatrics Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatrics Medicine.
Report Scope
The Pediatrics Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pediatrics Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatrics Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Novartis
Pfizer
Sanofi
Abbott
Bristol-Myers Squibb
Cipla
Eisai Pharmaceuticals
Eli Lilly
F. Hoffman-La Roche
Glenmark
Helsinn Healthcare
Heron Therapeutics
Ipca Laboratories
Lupin Pharmaceuticals
Merck Sharp & Dohme
RedHill
Sun Pharmaceutical Industries
Takeda Pharmaceutical
Segment by Type
Tablets
Caplets
Oral Liquid
Capsules
Other
Segment by Application
Respiratory diseases
Infectious diseases
Gastrointestinal diseases
CNS diseases
Oncological diseases
CVDs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatrics Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatrics Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tablets
1.2.3 Caplets
1.2.4 Oral Liquid
1.2.5 Capsules
1.2.6 Other
1.3 Market by Application
1.3.1 Global Pediatrics Medicine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Respiratory diseases
1.3.3 Infectious diseases
1.3.4 Gastrointestinal diseases
1.3.5 CNS diseases
1.3.6 Oncological diseases
1.3.7 CVDs
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatrics Medicine Market Perspective (2019-2030)
2.2 Pediatrics Medicine Growth Trends by Region
2.2.1 Global Pediatrics Medicine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pediatrics Medicine Historic Market Size by Region (2019-2024)
2.2.3 Pediatrics Medicine Forecasted Market Size by Region (2025-2030)
2.3 Pediatrics Medicine Market Dynamics
2.3.1 Pediatrics Medicine Industry Trends
2.3.2 Pediatrics Medicine Market Drivers
2.3.3 Pediatrics Medicine Market Challenges
2.3.4 Pediatrics Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatrics Medicine Players by Revenue
3.1.1 Global Top Pediatrics Medicine Players by Revenue (2019-2024)
3.1.2 Global Pediatrics Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Pediatrics Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pediatrics Medicine Revenue
3.4 Global Pediatrics Medicine Market Concentration Ratio
3.4.1 Global Pediatrics Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatrics Medicine Revenue in 2023
3.5 Pediatrics Medicine Key Players Head office and Area Served
3.6 Key Players Pediatrics Medicine Product Solution and Service
3.7 Date of Enter into Pediatrics Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatrics Medicine Breakdown Data by Type
4.1 Global Pediatrics Medicine Historic Market Size by Type (2019-2024)
4.2 Global Pediatrics Medicine Forecasted Market Size by Type (2025-2030)
5 Pediatrics Medicine Breakdown Data by Application
5.1 Global Pediatrics Medicine Historic Market Size by Application (2019-2024)
5.2 Global Pediatrics Medicine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pediatrics Medicine Market Size (2019-2030)
6.2 North America Pediatrics Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pediatrics Medicine Market Size by Country (2019-2024)
6.4 North America Pediatrics Medicine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatrics Medicine Market Size (2019-2030)
7.2 Europe Pediatrics Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pediatrics Medicine Market Size by Country (2019-2024)
7.4 Europe Pediatrics Medicine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatrics Medicine Market Size (2019-2030)
8.2 Asia-Pacific Pediatrics Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pediatrics Medicine Market Size by Region (2019-2024)
8.4 Asia-Pacific Pediatrics Medicine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatrics Medicine Market Size (2019-2030)
9.2 Latin America Pediatrics Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pediatrics Medicine Market Size by Country (2019-2024)
9.4 Latin America Pediatrics Medicine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatrics Medicine Market Size (2019-2030)
10.2 Middle East & Africa Pediatrics Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pediatrics Medicine Market Size by Country (2019-2024)
10.4 Middle East & Africa Pediatrics Medicine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Pediatrics Medicine Introduction
11.1.4 GSK Revenue in Pediatrics Medicine Business (2019-2024)
11.1.5 GSK Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Pediatrics Medicine Introduction
11.2.4 Novartis Revenue in Pediatrics Medicine Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Pediatrics Medicine Introduction
11.3.4 Pfizer Revenue in Pediatrics Medicine Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Pediatrics Medicine Introduction
11.4.4 Sanofi Revenue in Pediatrics Medicine Business (2019-2024)
11.4.5 Sanofi Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott Pediatrics Medicine Introduction
11.5.4 Abbott Revenue in Pediatrics Medicine Business (2019-2024)
11.5.5 Abbott Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Detail
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Pediatrics Medicine Introduction
11.6.4 Bristol-Myers Squibb Revenue in Pediatrics Medicine Business (2019-2024)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Cipla
11.7.1 Cipla Company Detail
11.7.2 Cipla Business Overview
11.7.3 Cipla Pediatrics Medicine Introduction
11.7.4 Cipla Revenue in Pediatrics Medicine Business (2019-2024)
11.7.5 Cipla Recent Development
11.8 Eisai Pharmaceuticals
11.8.1 Eisai Pharmaceuticals Company Detail
11.8.2 Eisai Pharmaceuticals Business Overview
11.8.3 Eisai Pharmaceuticals Pediatrics Medicine Introduction
11.8.4 Eisai Pharmaceuticals Revenue in Pediatrics Medicine Business (2019-2024)
11.8.5 Eisai Pharmaceuticals Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Detail
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Pediatrics Medicine Introduction
11.9.4 Eli Lilly Revenue in Pediatrics Medicine Business (2019-2024)
11.9.5 Eli Lilly Recent Development
11.10 F. Hoffman-La Roche
11.10.1 F. Hoffman-La Roche Company Detail
11.10.2 F. Hoffman-La Roche Business Overview
11.10.3 F. Hoffman-La Roche Pediatrics Medicine Introduction
11.10.4 F. Hoffman-La Roche Revenue in Pediatrics Medicine Business (2019-2024)
11.10.5 F. Hoffman-La Roche Recent Development
11.11 Glenmark
11.11.1 Glenmark Company Detail
11.11.2 Glenmark Business Overview
11.11.3 Glenmark Pediatrics Medicine Introduction
11.11.4 Glenmark Revenue in Pediatrics Medicine Business (2019-2024)
11.11.5 Glenmark Recent Development
11.12 Helsinn Healthcare
11.12.1 Helsinn Healthcare Company Detail
11.12.2 Helsinn Healthcare Business Overview
11.12.3 Helsinn Healthcare Pediatrics Medicine Introduction
11.12.4 Helsinn Healthcare Revenue in Pediatrics Medicine Business (2019-2024)
11.12.5 Helsinn Healthcare Recent Development
11.13 Heron Therapeutics
11.13.1 Heron Therapeutics Company Detail
11.13.2 Heron Therapeutics Business Overview
11.13.3 Heron Therapeutics Pediatrics Medicine Introduction
11.13.4 Heron Therapeutics Revenue in Pediatrics Medicine Business (2019-2024)
11.13.5 Heron Therapeutics Recent Development
11.14 Ipca Laboratories
11.14.1 Ipca Laboratories Company Detail
11.14.2 Ipca Laboratories Business Overview
11.14.3 Ipca Laboratories Pediatrics Medicine Introduction
11.14.4 Ipca Laboratories Revenue in Pediatrics Medicine Business (2019-2024)
11.14.5 Ipca Laboratories Recent Development
11.15 Lupin Pharmaceuticals
11.15.1 Lupin Pharmaceuticals Company Detail
11.15.2 Lupin Pharmaceuticals Business Overview
11.15.3 Lupin Pharmaceuticals Pediatrics Medicine Introduction
11.15.4 Lupin Pharmaceuticals Revenue in Pediatrics Medicine Business (2019-2024)
11.15.5 Lupin Pharmaceuticals Recent Development
11.16 Merck Sharp & Dohme
11.16.1 Merck Sharp & Dohme Company Detail
11.16.2 Merck Sharp & Dohme Business Overview
11.16.3 Merck Sharp & Dohme Pediatrics Medicine Introduction
11.16.4 Merck Sharp & Dohme Revenue in Pediatrics Medicine Business (2019-2024)
11.16.5 Merck Sharp & Dohme Recent Development
11.17 RedHill
11.17.1 RedHill Company Detail
11.17.2 RedHill Business Overview
11.17.3 RedHill Pediatrics Medicine Introduction
11.17.4 RedHill Revenue in Pediatrics Medicine Business (2019-2024)
11.17.5 RedHill Recent Development
11.18 Sun Pharmaceutical Industries
11.18.1 Sun Pharmaceutical Industries Company Detail
11.18.2 Sun Pharmaceutical Industries Business Overview
11.18.3 Sun Pharmaceutical Industries Pediatrics Medicine Introduction
11.18.4 Sun Pharmaceutical Industries Revenue in Pediatrics Medicine Business (2019-2024)
11.18.5 Sun Pharmaceutical Industries Recent Development
11.19 Takeda Pharmaceutical
11.19.1 Takeda Pharmaceutical Company Detail
11.19.2 Takeda Pharmaceutical Business Overview
11.19.3 Takeda Pharmaceutical Pediatrics Medicine Introduction
11.19.4 Takeda Pharmaceutical Revenue in Pediatrics Medicine Business (2019-2024)
11.19.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatrics Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tablets
1.2.3 Caplets
1.2.4 Oral Liquid
1.2.5 Capsules
1.2.6 Other
1.3 Market by Application
1.3.1 Global Pediatrics Medicine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Respiratory diseases
1.3.3 Infectious diseases
1.3.4 Gastrointestinal diseases
1.3.5 CNS diseases
1.3.6 Oncological diseases
1.3.7 CVDs
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatrics Medicine Market Perspective (2019-2030)
2.2 Pediatrics Medicine Growth Trends by Region
2.2.1 Global Pediatrics Medicine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pediatrics Medicine Historic Market Size by Region (2019-2024)
2.2.3 Pediatrics Medicine Forecasted Market Size by Region (2025-2030)
2.3 Pediatrics Medicine Market Dynamics
2.3.1 Pediatrics Medicine Industry Trends
2.3.2 Pediatrics Medicine Market Drivers
2.3.3 Pediatrics Medicine Market Challenges
2.3.4 Pediatrics Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatrics Medicine Players by Revenue
3.1.1 Global Top Pediatrics Medicine Players by Revenue (2019-2024)
3.1.2 Global Pediatrics Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Pediatrics Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pediatrics Medicine Revenue
3.4 Global Pediatrics Medicine Market Concentration Ratio
3.4.1 Global Pediatrics Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatrics Medicine Revenue in 2023
3.5 Pediatrics Medicine Key Players Head office and Area Served
3.6 Key Players Pediatrics Medicine Product Solution and Service
3.7 Date of Enter into Pediatrics Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatrics Medicine Breakdown Data by Type
4.1 Global Pediatrics Medicine Historic Market Size by Type (2019-2024)
4.2 Global Pediatrics Medicine Forecasted Market Size by Type (2025-2030)
5 Pediatrics Medicine Breakdown Data by Application
5.1 Global Pediatrics Medicine Historic Market Size by Application (2019-2024)
5.2 Global Pediatrics Medicine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pediatrics Medicine Market Size (2019-2030)
6.2 North America Pediatrics Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pediatrics Medicine Market Size by Country (2019-2024)
6.4 North America Pediatrics Medicine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatrics Medicine Market Size (2019-2030)
7.2 Europe Pediatrics Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pediatrics Medicine Market Size by Country (2019-2024)
7.4 Europe Pediatrics Medicine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatrics Medicine Market Size (2019-2030)
8.2 Asia-Pacific Pediatrics Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pediatrics Medicine Market Size by Region (2019-2024)
8.4 Asia-Pacific Pediatrics Medicine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatrics Medicine Market Size (2019-2030)
9.2 Latin America Pediatrics Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pediatrics Medicine Market Size by Country (2019-2024)
9.4 Latin America Pediatrics Medicine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatrics Medicine Market Size (2019-2030)
10.2 Middle East & Africa Pediatrics Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pediatrics Medicine Market Size by Country (2019-2024)
10.4 Middle East & Africa Pediatrics Medicine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Pediatrics Medicine Introduction
11.1.4 GSK Revenue in Pediatrics Medicine Business (2019-2024)
11.1.5 GSK Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Pediatrics Medicine Introduction
11.2.4 Novartis Revenue in Pediatrics Medicine Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Pediatrics Medicine Introduction
11.3.4 Pfizer Revenue in Pediatrics Medicine Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Pediatrics Medicine Introduction
11.4.4 Sanofi Revenue in Pediatrics Medicine Business (2019-2024)
11.4.5 Sanofi Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott Pediatrics Medicine Introduction
11.5.4 Abbott Revenue in Pediatrics Medicine Business (2019-2024)
11.5.5 Abbott Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Detail
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Pediatrics Medicine Introduction
11.6.4 Bristol-Myers Squibb Revenue in Pediatrics Medicine Business (2019-2024)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Cipla
11.7.1 Cipla Company Detail
11.7.2 Cipla Business Overview
11.7.3 Cipla Pediatrics Medicine Introduction
11.7.4 Cipla Revenue in Pediatrics Medicine Business (2019-2024)
11.7.5 Cipla Recent Development
11.8 Eisai Pharmaceuticals
11.8.1 Eisai Pharmaceuticals Company Detail
11.8.2 Eisai Pharmaceuticals Business Overview
11.8.3 Eisai Pharmaceuticals Pediatrics Medicine Introduction
11.8.4 Eisai Pharmaceuticals Revenue in Pediatrics Medicine Business (2019-2024)
11.8.5 Eisai Pharmaceuticals Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Detail
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Pediatrics Medicine Introduction
11.9.4 Eli Lilly Revenue in Pediatrics Medicine Business (2019-2024)
11.9.5 Eli Lilly Recent Development
11.10 F. Hoffman-La Roche
11.10.1 F. Hoffman-La Roche Company Detail
11.10.2 F. Hoffman-La Roche Business Overview
11.10.3 F. Hoffman-La Roche Pediatrics Medicine Introduction
11.10.4 F. Hoffman-La Roche Revenue in Pediatrics Medicine Business (2019-2024)
11.10.5 F. Hoffman-La Roche Recent Development
11.11 Glenmark
11.11.1 Glenmark Company Detail
11.11.2 Glenmark Business Overview
11.11.3 Glenmark Pediatrics Medicine Introduction
11.11.4 Glenmark Revenue in Pediatrics Medicine Business (2019-2024)
11.11.5 Glenmark Recent Development
11.12 Helsinn Healthcare
11.12.1 Helsinn Healthcare Company Detail
11.12.2 Helsinn Healthcare Business Overview
11.12.3 Helsinn Healthcare Pediatrics Medicine Introduction
11.12.4 Helsinn Healthcare Revenue in Pediatrics Medicine Business (2019-2024)
11.12.5 Helsinn Healthcare Recent Development
11.13 Heron Therapeutics
11.13.1 Heron Therapeutics Company Detail
11.13.2 Heron Therapeutics Business Overview
11.13.3 Heron Therapeutics Pediatrics Medicine Introduction
11.13.4 Heron Therapeutics Revenue in Pediatrics Medicine Business (2019-2024)
11.13.5 Heron Therapeutics Recent Development
11.14 Ipca Laboratories
11.14.1 Ipca Laboratories Company Detail
11.14.2 Ipca Laboratories Business Overview
11.14.3 Ipca Laboratories Pediatrics Medicine Introduction
11.14.4 Ipca Laboratories Revenue in Pediatrics Medicine Business (2019-2024)
11.14.5 Ipca Laboratories Recent Development
11.15 Lupin Pharmaceuticals
11.15.1 Lupin Pharmaceuticals Company Detail
11.15.2 Lupin Pharmaceuticals Business Overview
11.15.3 Lupin Pharmaceuticals Pediatrics Medicine Introduction
11.15.4 Lupin Pharmaceuticals Revenue in Pediatrics Medicine Business (2019-2024)
11.15.5 Lupin Pharmaceuticals Recent Development
11.16 Merck Sharp & Dohme
11.16.1 Merck Sharp & Dohme Company Detail
11.16.2 Merck Sharp & Dohme Business Overview
11.16.3 Merck Sharp & Dohme Pediatrics Medicine Introduction
11.16.4 Merck Sharp & Dohme Revenue in Pediatrics Medicine Business (2019-2024)
11.16.5 Merck Sharp & Dohme Recent Development
11.17 RedHill
11.17.1 RedHill Company Detail
11.17.2 RedHill Business Overview
11.17.3 RedHill Pediatrics Medicine Introduction
11.17.4 RedHill Revenue in Pediatrics Medicine Business (2019-2024)
11.17.5 RedHill Recent Development
11.18 Sun Pharmaceutical Industries
11.18.1 Sun Pharmaceutical Industries Company Detail
11.18.2 Sun Pharmaceutical Industries Business Overview
11.18.3 Sun Pharmaceutical Industries Pediatrics Medicine Introduction
11.18.4 Sun Pharmaceutical Industries Revenue in Pediatrics Medicine Business (2019-2024)
11.18.5 Sun Pharmaceutical Industries Recent Development
11.19 Takeda Pharmaceutical
11.19.1 Takeda Pharmaceutical Company Detail
11.19.2 Takeda Pharmaceutical Business Overview
11.19.3 Takeda Pharmaceutical Pediatrics Medicine Introduction
11.19.4 Takeda Pharmaceutical Revenue in Pediatrics Medicine Business (2019-2024)
11.19.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Pediatrics Medicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tablets
Table 3. Key Players of Caplets
Table 4. Key Players of Oral Liquid
Table 5. Key Players of Capsules
Table 6. Key Players of Other
Table 7. Global Pediatrics Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Pediatrics Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Pediatrics Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Pediatrics Medicine Market Share by Region (2019-2024)
Table 11. Global Pediatrics Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Pediatrics Medicine Market Share by Region (2025-2030)
Table 13. Pediatrics Medicine Market Trends
Table 14. Pediatrics Medicine Market Drivers
Table 15. Pediatrics Medicine Market Challenges
Table 16. Pediatrics Medicine Market Restraints
Table 17. Global Pediatrics Medicine Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Pediatrics Medicine Market Share by Players (2019-2024)
Table 19. Global Top Pediatrics Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatrics Medicine as of 2023)
Table 20. Ranking of Global Top Pediatrics Medicine Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Pediatrics Medicine Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pediatrics Medicine Product Solution and Service
Table 24. Date of Enter into Pediatrics Medicine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pediatrics Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Pediatrics Medicine Revenue Market Share by Type (2019-2024)
Table 28. Global Pediatrics Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Pediatrics Medicine Revenue Market Share by Type (2025-2030)
Table 30. Global Pediatrics Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Pediatrics Medicine Revenue Market Share by Application (2019-2024)
Table 32. Global Pediatrics Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Pediatrics Medicine Revenue Market Share by Application (2025-2030)
Table 34. North America Pediatrics Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Pediatrics Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Pediatrics Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Pediatrics Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Pediatrics Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Pediatrics Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Pediatrics Medicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Pediatrics Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Pediatrics Medicine Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Pediatrics Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Pediatrics Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Pediatrics Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Pediatrics Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Pediatrics Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Pediatrics Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 49. GSK Company Detail
Table 50. GSK Business Overview
Table 51. GSK Pediatrics Medicine Product
Table 52. GSK Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 53. GSK Recent Development
Table 54. Novartis Company Detail
Table 55. Novartis Business Overview
Table 56. Novartis Pediatrics Medicine Product
Table 57. Novartis Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 58. Novartis Recent Development
Table 59. Pfizer Company Detail
Table 60. Pfizer Business Overview
Table 61. Pfizer Pediatrics Medicine Product
Table 62. Pfizer Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 63. Pfizer Recent Development
Table 64. Sanofi Company Detail
Table 65. Sanofi Business Overview
Table 66. Sanofi Pediatrics Medicine Product
Table 67. Sanofi Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 68. Sanofi Recent Development
Table 69. Abbott Company Detail
Table 70. Abbott Business Overview
Table 71. Abbott Pediatrics Medicine Product
Table 72. Abbott Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 73. Abbott Recent Development
Table 74. Bristol-Myers Squibb Company Detail
Table 75. Bristol-Myers Squibb Business Overview
Table 76. Bristol-Myers Squibb Pediatrics Medicine Product
Table 77. Bristol-Myers Squibb Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 78. Bristol-Myers Squibb Recent Development
Table 79. Cipla Company Detail
Table 80. Cipla Business Overview
Table 81. Cipla Pediatrics Medicine Product
Table 82. Cipla Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 83. Cipla Recent Development
Table 84. Eisai Pharmaceuticals Company Detail
Table 85. Eisai Pharmaceuticals Business Overview
Table 86. Eisai Pharmaceuticals Pediatrics Medicine Product
Table 87. Eisai Pharmaceuticals Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 88. Eisai Pharmaceuticals Recent Development
Table 89. Eli Lilly Company Detail
Table 90. Eli Lilly Business Overview
Table 91. Eli Lilly Pediatrics Medicine Product
Table 92. Eli Lilly Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 93. Eli Lilly Recent Development
Table 94. F. Hoffman-La Roche Company Detail
Table 95. F. Hoffman-La Roche Business Overview
Table 96. F. Hoffman-La Roche Pediatrics Medicine Product
Table 97. F. Hoffman-La Roche Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 98. F. Hoffman-La Roche Recent Development
Table 99. Glenmark Company Detail
Table 100. Glenmark Business Overview
Table 101. Glenmark Pediatrics Medicine Product
Table 102. Glenmark Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 103. Glenmark Recent Development
Table 104. Helsinn Healthcare Company Detail
Table 105. Helsinn Healthcare Business Overview
Table 106. Helsinn Healthcare Pediatrics Medicine Product
Table 107. Helsinn Healthcare Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 108. Helsinn Healthcare Recent Development
Table 109. Heron Therapeutics Company Detail
Table 110. Heron Therapeutics Business Overview
Table 111. Heron Therapeutics Pediatrics Medicine Product
Table 112. Heron Therapeutics Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 113. Heron Therapeutics Recent Development
Table 114. Ipca Laboratories Company Detail
Table 115. Ipca Laboratories Business Overview
Table 116. Ipca Laboratories Pediatrics Medicine Product
Table 117. Ipca Laboratories Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 118. Ipca Laboratories Recent Development
Table 119. Lupin Pharmaceuticals Company Detail
Table 120. Lupin Pharmaceuticals Business Overview
Table 121. Lupin Pharmaceuticals Pediatrics Medicine Product
Table 122. Lupin Pharmaceuticals Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 123. Lupin Pharmaceuticals Recent Development
Table 124. Merck Sharp & Dohme Company Detail
Table 125. Merck Sharp & Dohme Business Overview
Table 126. Merck Sharp & Dohme Pediatrics Medicine Product
Table 127. Merck Sharp & Dohme Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 128. Merck Sharp & Dohme Recent Development
Table 129. RedHill Company Detail
Table 130. RedHill Business Overview
Table 131. RedHill Pediatrics Medicine Product
Table 132. RedHill Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 133. RedHill Recent Development
Table 134. Sun Pharmaceutical Industries Company Detail
Table 135. Sun Pharmaceutical Industries Business Overview
Table 136. Sun Pharmaceutical Industries Pediatrics Medicine Product
Table 137. Sun Pharmaceutical Industries Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 138. Sun Pharmaceutical Industries Recent Development
Table 139. Takeda Pharmaceutical Company Detail
Table 140. Takeda Pharmaceutical Business Overview
Table 141. Takeda Pharmaceutical Pediatrics Medicine Product
Table 142. Takeda Pharmaceutical Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 143. Takeda Pharmaceutical Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatrics Medicine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pediatrics Medicine Market Share by Type: 2023 VS 2030
Figure 3. Tablets Features
Figure 4. Caplets Features
Figure 5. Oral Liquid Features
Figure 6. Capsules Features
Figure 7. Other Features
Figure 8. Global Pediatrics Medicine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Pediatrics Medicine Market Share by Application: 2023 VS 2030
Figure 10. Respiratory diseases Case Studies
Figure 11. Infectious diseases Case Studies
Figure 12. Gastrointestinal diseases Case Studies
Figure 13. CNS diseases Case Studies
Figure 14. Oncological diseases Case Studies
Figure 15. CVDs Case Studies
Figure 16. Others Case Studies
Figure 17. Pediatrics Medicine Report Years Considered
Figure 18. Global Pediatrics Medicine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 19. Global Pediatrics Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 20. Global Pediatrics Medicine Market Share by Region: 2023 VS 2030
Figure 21. Global Pediatrics Medicine Market Share by Players in 2023
Figure 22. Global Top Pediatrics Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatrics Medicine as of 2023)
Figure 23. The Top 10 and 5 Players Market Share by Pediatrics Medicine Revenue in 2023
Figure 24. North America Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. North America Pediatrics Medicine Market Share by Country (2019-2030)
Figure 26. United States Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Canada Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Pediatrics Medicine Market Share by Country (2019-2030)
Figure 30. Germany Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. France Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. U.K. Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Italy Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Russia Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Nordic Countries Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Asia-Pacific Pediatrics Medicine Market Share by Region (2019-2030)
Figure 38. China Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Japan Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. South Korea Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. India Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Australia Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Latin America Pediatrics Medicine Market Share by Country (2019-2030)
Figure 46. Mexico Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Brazil Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Pediatrics Medicine Market Share by Country (2019-2030)
Figure 50. Turkey Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. GSK Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 53. Novartis Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 54. Pfizer Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 55. Sanofi Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 56. Abbott Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 58. Cipla Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 59. Eisai Pharmaceuticals Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 60. Eli Lilly Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 61. F. Hoffman-La Roche Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 62. Glenmark Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 63. Helsinn Healthcare Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 64. Heron Therapeutics Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 65. Ipca Laboratories Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 66. Lupin Pharmaceuticals Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 67. Merck Sharp & Dohme Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 68. RedHill Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 69. Sun Pharmaceutical Industries Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 70. Takeda Pharmaceutical Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Table 1. Global Pediatrics Medicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tablets
Table 3. Key Players of Caplets
Table 4. Key Players of Oral Liquid
Table 5. Key Players of Capsules
Table 6. Key Players of Other
Table 7. Global Pediatrics Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Pediatrics Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Pediatrics Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Pediatrics Medicine Market Share by Region (2019-2024)
Table 11. Global Pediatrics Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Pediatrics Medicine Market Share by Region (2025-2030)
Table 13. Pediatrics Medicine Market Trends
Table 14. Pediatrics Medicine Market Drivers
Table 15. Pediatrics Medicine Market Challenges
Table 16. Pediatrics Medicine Market Restraints
Table 17. Global Pediatrics Medicine Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Pediatrics Medicine Market Share by Players (2019-2024)
Table 19. Global Top Pediatrics Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatrics Medicine as of 2023)
Table 20. Ranking of Global Top Pediatrics Medicine Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Pediatrics Medicine Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pediatrics Medicine Product Solution and Service
Table 24. Date of Enter into Pediatrics Medicine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pediatrics Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Pediatrics Medicine Revenue Market Share by Type (2019-2024)
Table 28. Global Pediatrics Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Pediatrics Medicine Revenue Market Share by Type (2025-2030)
Table 30. Global Pediatrics Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Pediatrics Medicine Revenue Market Share by Application (2019-2024)
Table 32. Global Pediatrics Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Pediatrics Medicine Revenue Market Share by Application (2025-2030)
Table 34. North America Pediatrics Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Pediatrics Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Pediatrics Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Pediatrics Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Pediatrics Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Pediatrics Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Pediatrics Medicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Pediatrics Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Pediatrics Medicine Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Pediatrics Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Pediatrics Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Pediatrics Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Pediatrics Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Pediatrics Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Pediatrics Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 49. GSK Company Detail
Table 50. GSK Business Overview
Table 51. GSK Pediatrics Medicine Product
Table 52. GSK Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 53. GSK Recent Development
Table 54. Novartis Company Detail
Table 55. Novartis Business Overview
Table 56. Novartis Pediatrics Medicine Product
Table 57. Novartis Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 58. Novartis Recent Development
Table 59. Pfizer Company Detail
Table 60. Pfizer Business Overview
Table 61. Pfizer Pediatrics Medicine Product
Table 62. Pfizer Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 63. Pfizer Recent Development
Table 64. Sanofi Company Detail
Table 65. Sanofi Business Overview
Table 66. Sanofi Pediatrics Medicine Product
Table 67. Sanofi Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 68. Sanofi Recent Development
Table 69. Abbott Company Detail
Table 70. Abbott Business Overview
Table 71. Abbott Pediatrics Medicine Product
Table 72. Abbott Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 73. Abbott Recent Development
Table 74. Bristol-Myers Squibb Company Detail
Table 75. Bristol-Myers Squibb Business Overview
Table 76. Bristol-Myers Squibb Pediatrics Medicine Product
Table 77. Bristol-Myers Squibb Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 78. Bristol-Myers Squibb Recent Development
Table 79. Cipla Company Detail
Table 80. Cipla Business Overview
Table 81. Cipla Pediatrics Medicine Product
Table 82. Cipla Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 83. Cipla Recent Development
Table 84. Eisai Pharmaceuticals Company Detail
Table 85. Eisai Pharmaceuticals Business Overview
Table 86. Eisai Pharmaceuticals Pediatrics Medicine Product
Table 87. Eisai Pharmaceuticals Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 88. Eisai Pharmaceuticals Recent Development
Table 89. Eli Lilly Company Detail
Table 90. Eli Lilly Business Overview
Table 91. Eli Lilly Pediatrics Medicine Product
Table 92. Eli Lilly Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 93. Eli Lilly Recent Development
Table 94. F. Hoffman-La Roche Company Detail
Table 95. F. Hoffman-La Roche Business Overview
Table 96. F. Hoffman-La Roche Pediatrics Medicine Product
Table 97. F. Hoffman-La Roche Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 98. F. Hoffman-La Roche Recent Development
Table 99. Glenmark Company Detail
Table 100. Glenmark Business Overview
Table 101. Glenmark Pediatrics Medicine Product
Table 102. Glenmark Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 103. Glenmark Recent Development
Table 104. Helsinn Healthcare Company Detail
Table 105. Helsinn Healthcare Business Overview
Table 106. Helsinn Healthcare Pediatrics Medicine Product
Table 107. Helsinn Healthcare Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 108. Helsinn Healthcare Recent Development
Table 109. Heron Therapeutics Company Detail
Table 110. Heron Therapeutics Business Overview
Table 111. Heron Therapeutics Pediatrics Medicine Product
Table 112. Heron Therapeutics Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 113. Heron Therapeutics Recent Development
Table 114. Ipca Laboratories Company Detail
Table 115. Ipca Laboratories Business Overview
Table 116. Ipca Laboratories Pediatrics Medicine Product
Table 117. Ipca Laboratories Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 118. Ipca Laboratories Recent Development
Table 119. Lupin Pharmaceuticals Company Detail
Table 120. Lupin Pharmaceuticals Business Overview
Table 121. Lupin Pharmaceuticals Pediatrics Medicine Product
Table 122. Lupin Pharmaceuticals Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 123. Lupin Pharmaceuticals Recent Development
Table 124. Merck Sharp & Dohme Company Detail
Table 125. Merck Sharp & Dohme Business Overview
Table 126. Merck Sharp & Dohme Pediatrics Medicine Product
Table 127. Merck Sharp & Dohme Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 128. Merck Sharp & Dohme Recent Development
Table 129. RedHill Company Detail
Table 130. RedHill Business Overview
Table 131. RedHill Pediatrics Medicine Product
Table 132. RedHill Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 133. RedHill Recent Development
Table 134. Sun Pharmaceutical Industries Company Detail
Table 135. Sun Pharmaceutical Industries Business Overview
Table 136. Sun Pharmaceutical Industries Pediatrics Medicine Product
Table 137. Sun Pharmaceutical Industries Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 138. Sun Pharmaceutical Industries Recent Development
Table 139. Takeda Pharmaceutical Company Detail
Table 140. Takeda Pharmaceutical Business Overview
Table 141. Takeda Pharmaceutical Pediatrics Medicine Product
Table 142. Takeda Pharmaceutical Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)
Table 143. Takeda Pharmaceutical Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatrics Medicine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pediatrics Medicine Market Share by Type: 2023 VS 2030
Figure 3. Tablets Features
Figure 4. Caplets Features
Figure 5. Oral Liquid Features
Figure 6. Capsules Features
Figure 7. Other Features
Figure 8. Global Pediatrics Medicine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Pediatrics Medicine Market Share by Application: 2023 VS 2030
Figure 10. Respiratory diseases Case Studies
Figure 11. Infectious diseases Case Studies
Figure 12. Gastrointestinal diseases Case Studies
Figure 13. CNS diseases Case Studies
Figure 14. Oncological diseases Case Studies
Figure 15. CVDs Case Studies
Figure 16. Others Case Studies
Figure 17. Pediatrics Medicine Report Years Considered
Figure 18. Global Pediatrics Medicine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 19. Global Pediatrics Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 20. Global Pediatrics Medicine Market Share by Region: 2023 VS 2030
Figure 21. Global Pediatrics Medicine Market Share by Players in 2023
Figure 22. Global Top Pediatrics Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatrics Medicine as of 2023)
Figure 23. The Top 10 and 5 Players Market Share by Pediatrics Medicine Revenue in 2023
Figure 24. North America Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. North America Pediatrics Medicine Market Share by Country (2019-2030)
Figure 26. United States Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Canada Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Pediatrics Medicine Market Share by Country (2019-2030)
Figure 30. Germany Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. France Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. U.K. Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Italy Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Russia Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Nordic Countries Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Asia-Pacific Pediatrics Medicine Market Share by Region (2019-2030)
Figure 38. China Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Japan Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. South Korea Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. India Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Australia Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Latin America Pediatrics Medicine Market Share by Country (2019-2030)
Figure 46. Mexico Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Brazil Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Pediatrics Medicine Market Share by Country (2019-2030)
Figure 50. Turkey Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. GSK Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 53. Novartis Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 54. Pfizer Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 55. Sanofi Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 56. Abbott Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 58. Cipla Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 59. Eisai Pharmaceuticals Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 60. Eli Lilly Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 61. F. Hoffman-La Roche Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 62. Glenmark Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 63. Helsinn Healthcare Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 64. Heron Therapeutics Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 65. Ipca Laboratories Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 66. Lupin Pharmaceuticals Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 67. Merck Sharp & Dohme Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 68. RedHill Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 69. Sun Pharmaceutical Industries Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 70. Takeda Pharmaceutical Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232